J&J’s revenues in India are in the billions of dollars spread across orthopedics, pharmaceuticals, vision care and more.
Jacksonville, FL, headquartered Johnson & Johnson Vision, the eye health division of Johnson & Johnson, is intensifying its focus on India by developing region-specific innovations, clinical trials, and expanding local collaborations. Christoph Vonwiller, president of Vision for Asia-Pacific, emphasized India’s importance due to its vast market potential and rising demand for advanced eye care.
Key initiatives include:
- Innovation Pipeline: India is being positioned as a central hub for ophthalmic innovation in the Asia-Pacific region, with several new products already launched and more on the way.
- Market Growth: India’s ophthalmic market, valued at approximately $1.8 billion in 2024, is expanding steadily due to an aging population and increasing vision-related diseases.
- Cataract Focus: Cataracts account for nearly 80% of blindness in India, driving demand for surgeries and corrective solutions.
- Local Partnerships: J&J Vision is co-developing solutions with Indian ophthalmologists to better meet local needs and improve clinical outcomes.
- Digital Expansion: Over 300 Indian surgeons use J&J Vision’s e-platforms to stay updated on the latest advancements, reflecting the company’s push into digital health.
- Manufacturing Localization: Plans are underway to optimize supply chains and localize production to improve accessibility and affordability.
- R&D Leadership: India was the launch site for the SILK refractive surgery procedure, and continues to be a key source of feedback and data for refining innovations.
- Community Outreach: Through the Sight for Kids initiative with Lions Clubs International Foundation, J&J Vision has conducted over 28 million vision assessments and aims to reach 7 million children in India by 2029, especially in rural areas.
Last updated: December 26th, 2025
